? e-coli ?
https://www.google.com/search?q=antibacterial+resistant+bacteria+e-coli+from+human+feces&rlz=1C1CHZN_enNZ947NZ947&ei=PFSwZOmjA8XV1e8Px_ausAw&ved=0ahUKEwjpscWKuYyAAxXFavUHHUe7C8YQ4dUDCBA&uact=5&oq=antibacterial+resistant+bacteria+e-coli+from+human+feces&gs_lcp=Cgxnd3Mtd2l6LXNlcnAQAzIFCAAQogQyBQgAEKIEMgUIABCiBDIFCAAQogQyBQgAEKIEOgoIABBHENYEELADSgQIQRgAUJRgWOF4YLl8aANwAHgAgAHWAYgBjgaSAQUwLjIuMpgBAKABAcABAcgBCA&sclient=gws-wiz-serp
https://www.pharmaceutical-technology.com/uncategorized/recce-327-recce-pharmaceuticals-escherichia-coli-infections-likelihood-of-approval/
.
- Forums
- ASX - By Stock
- RCE
- Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study
RCE
recce pharmaceuticals ltd
Add to My Watchlist
6.90%
!
31.0¢

Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
29.0¢ | 32.8¢ | 29.0¢ | $78.39K | 251.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 916 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 114230 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 916 | 0.295 |
2 | 19274 | 0.290 |
4 | 133518 | 0.285 |
11 | 309806 | 0.280 |
3 | 33509 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 114230 | 1 |
0.350 | 25000 | 2 |
0.375 | 8002 | 1 |
0.380 | 6820 | 2 |
0.385 | 17985 | 2 |
Last trade - 15.59pm 25/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |